Protective measures

advises that risk is limited to areas not usually visited by travelers and recommends that only travelers likely to have evening or nighttime exposure in risk areas undertake chemoprophylaxis with mefloquine in addition to personal protective measures. Persons with epilepsy, psychiatric disorders or known hypersensitivity to mefloquine should not use this drug and should consider alternate means of protection. Consult your physician regarding additional precautions and potential side effects.